Collaboration Between PhRMA and Scientific American Highlights Biomedical Science

Bill Chin, M.D.
Bill Chin, M.D. October 20, 2014
Share This

Scientific progress is complex, time-consuming and expensive. Researchers continue to broaden our collective understanding of disease with the hope that new findings will lead to advancements that make a real difference for patients. 

To highlight the challenges and opportunities in biomedical science, PhRMA and Scientific American - a leading source and authority on science, technology and policy - are collaborating on a new website to present unique content and commentary.

Benchmarks: Science Fueling Health showcases efforts in drug discovery and health innovation, with in-depth stories on groundbreaking research, coordinated approaches to progress and various perspectives on the development of medicines.  It will highlight ways in which biopharmaceutical companies work collaboratively and pre-competitively with academia, government, and patient advocacy organizations, such as the recently established Accelerating Medicines Partnership (AMP), in which the U.S. National Institutes of Health (NIH), ten biopharmaceutical companies, PhRMA and nonprofit disease foundations have come together to find new treatments for hard-to-treat diseases including Alzheimer’s, type 2 diabetes and autoimmune disorders. 

Benchmarks will also incorporate the ever-important voice of patients in the process of finding new therapies. The website offers patient perspectives on topics such as finding and participating in clinical trials through the Michael J. Fox Foundation for Parkinson’s Research Fox Trial Finder, and the day-to-day impact of disease.

Visit www.sciambenchmarks.com and check back often to learn more about innovation in biomedical science. 


Topics: Research and Development, Alzheimer's, Patients, Clinical Trials